REQUIREMENT OF A 5-LIPOXYGENASE-ACTIVATING PROTEIN FOR LEUKOTRIENE SYNTHESIS

被引:706
作者
DIXON, RAF
DIEHL, RE
OPAS, E
RANDS, E
VICKERS, PJ
EVANS, JF
GILLARD, JW
MILLER, DK
机构
[1] MERCK SHARP & DOHME LTD,DEPT IMMUNOL,W POINT,PA 19486
[2] MERCK SHARP & DOHME LTD,DEPT BIOCHEM,W POINT,PA 19486
[3] MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065
[4] MERCK FROSST CTR THERAPEUT RES,DEPT PHARMACOL,POINTE CLAIRE H9R 4P8,QUEBEC,CANADA
[5] MERCK FROSST CTR THERAPEUT RES,DEPT MED CHEM,POINTE CLAIRE H9R 4P8,QUEBEC,CANADA
关键词
D O I
10.1038/343282a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
LEUKOTRIENES, the biologically active metabolites of arachidonic acid, have been implicated in a variety of inflammatory responses, including asthma, arthritis and psoriasis1,2. Recently a compound, MK-886, has been described that blocks the synthesis of leukotrienes in intact activated leukocytes, but has little or no effect on enzymes involved in leukotriene synthesis, including 5-lipoxygenase, in cell-free systems3. A membrane protein with a high affinity for MK-886 and possibly representing the cellular target for MK-886 has been isolated from rat and human leukocytes4. Here, we report the isolation of a complementary DNA clone encoding the MK-886-binding protein. We also demonstrate that the expression of both the MK-886-binding protein and 5-lipoxygenase is necessary for leukotriene synthesis in intact cells. Because the MK-886-binding protein seems to play a part in activating this enzyme in cells, it is termed the five-lipoxygenase activating protein (FLAP). © 1990 Nature Publishing Group.
引用
收藏
页码:282 / 284
页数:3
相关论文
共 22 条
[2]  
CHARGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294
[3]   CLONING OF THE GENE AND CDNA FOR MAMMALIAN BETA-ADRENERGIC-RECEPTOR AND HOMOLOGY WITH RHODOPSIN [J].
DIXON, RAF ;
KOBILKA, BK ;
STRADER, DJ ;
BENOVIC, JL ;
DOHLMAN, HG ;
FRIELLE, T ;
BOLANOWSKI, MA ;
BENNETT, CD ;
RANDS, E ;
DIEHL, RE ;
MUMFORD, RA ;
SLATER, EE ;
SIGAL, IS ;
CARON, MG ;
LEFKOWITZ, RJ ;
STRADER, CD .
NATURE, 1986, 321 (6065) :75-79
[4]   CLONING OF THE CDNA FOR HUMAN 5-LIPOXYGENASE [J].
DIXON, RAF ;
JONES, RE ;
DIEHL, RE ;
BENNETT, CD ;
KARGMAN, S ;
ROUZER, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) :416-420
[5]   LIGAND-BINDING TO THE BETA-ADRENERGIC-RECEPTOR INVOLVES ITS RHODOPSIN-LIKE CORE [J].
DIXON, RAF ;
SIGAL, IS ;
RANDS, E ;
REGISTER, RB ;
CANDELORE, MR ;
BLAKE, AD ;
STRADER, CD .
NATURE, 1987, 326 (6108) :73-77
[6]   ANALYSIS OF MEMBRANE AND SURFACE PROTEIN SEQUENCES WITH THE HYDROPHOBIC MOMENT PLOT [J].
EISENBERG, D ;
SCHWARZ, E ;
KOMAROMY, M ;
WALL, R .
JOURNAL OF MOLECULAR BIOLOGY, 1984, 179 (01) :125-142
[7]   PURIFICATION AND CHARACTERIZATION OF LEUKOTRIENE-A4 HYDROLASE FROM RAT NEUTROPHILS [J].
EVANS, JF ;
DUPUIS, P ;
FORDHUTCHINSON, AW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 840 (01) :43-50
[8]   L-663,536 (MK-886) (3-[1-(4-CHLOROBENZYL)-3-T-BUTYL-THIO-5-ISOPROPYLINDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID), A NOVEL, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR [J].
GILLARD, J ;
FORDHUTCHINSON, AW ;
CHAN, C ;
CHARLESON, S ;
DENIS, D ;
FOSTER, A ;
FORTIN, R ;
LEGER, S ;
MCFARLANE, CS ;
MORTON, H ;
PIECHUTA, H ;
RIENDEAU, D ;
ROUZER, CA ;
ROKACH, J ;
YOUNG, R ;
MACINTYRE, DE ;
PETERSON, L ;
BACH, T ;
EIERMANN, G ;
HOPPLE, S ;
HUMES, J ;
HUPE, L ;
LUELL, S ;
METZGER, J ;
MEURER, R ;
MILLER, DK ;
OPAS, E ;
PACHOLOK, S .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (05) :456-464
[9]  
GUINDON Y, 1984, Patent No. 115394
[10]   INHIBITION BY PROSTAGLANDINS OF LEUKOTRIENE-B4 RELEASE FROM ACTIVATED NEUTROPHILS [J].
HAM, EA ;
SODERMAN, DD ;
ZANETTI, ME ;
DOUGHERTY, HW ;
MCCAULEY, E ;
KUEHL, FA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4349-4353